Groupe la Francaise’s Tourmaline Bio TRML Stock Holding History

Groupe la Francaise’s Portfolio TRML Stock Details TRML Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-17,998	Closed	-$861K	–	762
2025 Q3	$861K	Buy	+17,998	New	+$499K	0.01%	297

Groupe la Francaise's TRML Position: Q4 2025 in Review

Groupe la Francaise sold out of Tourmaline Bio (TRML) in Q4 2025, closing a stake of 17,998 shares — an estimated $861K sold.

Groupe la Francaise first reported a position in TRML in Q3 2025 and held it in 1 quarter. The position peaked at $861K in Q3 2025. 0 funds tracked by Wall St. Rank hold TRML as of Q4 2025.

Groupe la Francaise reported no remaining Tourmaline Bio position as of Q4 2025 after selling out during the quarter.
Groupe la Francaise sold 17,998 Tourmaline Bio shares in Q4 2025, an estimated $861K.
Groupe la Francaise first reported a position in Tourmaline Bio in Q3 2025 and held it in 1 quarter.
Groupe la Francaise's Tourmaline Bio position peaked at $861K in Q3 2025.
0 funds tracked by Wall St. Rank held Tourmaline Bio as of Q4 2025.

Based on Groupe la Francaise's 13F filing for Q4 2025, filed 12 Feb 2026.